Felodipine protects human atrial muscle from hypoxia-reoxygenation dysfunction: A force-frequency relationship study in an in vitro model of stunning

International Journal of Cardiology

Volumn 62, Issue 2, 1997, Pages 107-132

  Iwashiro, Katsunori ^a   Criniti, Anna ^a   Sinatra, Riccardo ^a   Dawodu, Amos Adeyemo ^a   D'Amati, Giulia ^b   Monti, Francesco ^a   Pannarale, Luigi ^a   Bernucci, Paola ^a   Brancaccio, Gian Luca ^a   Vetuschi, Antonella ^b   Gaudio, Eugenio ^b   Gallo, Pietro ^a   Puddu, Paolo Emilio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Analysis of variance; Calcium entry blockers; Developed tension; Electron microscopy; Felodipine; Force frequency relationship; Greenhouse Geisser correction; Histomorphometry; Human atrial contractility; Human atrial electrophysiology; Human atrial trabeculae; Hypoxia; Myocardial protection; Post pausal potentiation; Reoxygenation injury; Stunning

Indexed keywords

FELODIPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HEART ATRIUM MUSCLE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANOXIA; CALCIUM CHANNEL BLOCKERS; CULTURE TECHNIQUES; DOBUTAMINE; FELODIPINE; FEMALE; HEART ATRIA; HEMODYNAMIC PROCESSES; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; PILOT PROJECTS; SARCOMERES;

EID: 0031442059     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00189-7     Document Type: Article

References (65)

1. Tyberg J.V., Yeatman L.A., Parmley W.W., Urschel C.W., Sonnenblick E.H. Effects of hypoxia on mechanics of cardiac contraction. Am J Physiol. 218:1970;1780-1788.
2. St. John Sutton M.G., Ritman E.L., Paradise N.F. Biphasic changes in maximum relaxation rate during progressive hypoxia in isometric kitten papillary muscle and isovolumic rabbit ventricle. Circ Res. 47:1980;516-524.
3. Paradise N.F., Schmitter J.L., Surmitis J.M. Criteria for adequate oxygenation of isometric kitten papillary muscle. Am J Physiol. 241:1981;H348-H353.
4. Brooks W.W., Sturckow B., Bing O.H.L. Myocardial hypoxia and reoxygenation: electrophysiologic and mechanical correlates. Am J Physiol. 226:1974;523-527.
5. Bing O.H.L., Brooks W.W., Messer J.V. Prolongation of tension on reoxygenation following myocardial hypoxia: a possible role for mitochondria in muscle relaxation. J Mol Cell Cardiol. 8:1976;205-215.
6. + loss, reduction in repolarization time, and tissue ATP levels during myocardial hypoxia and ischemia. Circ Res. 72:1993;560-570.
7. Schiariti M., Puddu P.E., Rouet R. Multivariate prediction of spontaneous repetitive responses in ventricular myocardium exposed in vitro to simulated ischemic conditions. Int J Cardiol. 45:1994;9-22.
8. ATP channels limits energy depletion in the guinea pig heart. Am J Physiol. 269:1995;H734-H742.
9. Hearse D.J. Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res. 28:1994;1737-1744.
10. Yang T., Tande P.M., Lathrop D.A., Refsum H. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes. Cardiovasc Res. 26:1992;1109-1115.
11. Shizukuda Y., Mallet R.T., Lee S.C., Downey H.F. Hypoxic preconditioning of ischaemic canine myocardium. Cardiovasc Res. 26:1992;534-542.
12. Walker D.M., Marber M.S., Walker J.M., Yellon D.M. Preconditioning in isolated superfused rabbit papillary muscle. Am J Physiol. 266:1994;H1534-H1540.
13. Bright C.M., Ellis D. Hypoxia-induced intracellular acidification in isolated sheep heart Purkinje fibres and the effects of temperature. J Mol Cell Cardiol. 26:1994;463-469.
14. Lasley R.D., Anderson G.M., Mentzer R.M.J. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res. 27:1993;565-570.
15. Engelman D.T., Watanabe M., Engelman R.M., Rousou J.A., Kisin E., Kagan V.E., Maulik N., Das D.K. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res. 29:1995;133-140.
16. Watanabe H., Yokosawa T., Eguchi S., Imai S. Difference in the mechanical response to a cardioplegic solution observed between the neonatal and the adult guinea pig myocardium. J Thorac Cardiovasc Surg. 97:1989;59-66.
17. + channels enhances myocardial protection due to cold high potassium cardioplegia: a force-frequency relationship study. J Mol Cell Cardiol. 27:1995;1867-1881.
18. Buckley N.M., Penefsky Z.J., Litwak R.S. Comparative force-frequency relationships in human and other mammalian ventricular myocardium. Pflugers Arch. 332:1972;259-270.
19. Mulieri L.A., Hasenfuss G., Leavitt B., Allen P.D., Alpert N.R. Altered myocardial force-frequency relation in human heart failure. Circulation. 85:1992;1743-1750.
20. Schwinger R.H.G., Böhm M., Mueller-Ehmsen J., Uhlmann R., Schmidt U., Staeblein A., Überfuhr P., Kreuzer E., Reichart B., Eissner H.J., Erdmann E. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation. 88(Part 1):1993;2267-2276.
21. + cardioplegia. Int J Cardiol. 48:1995;11-25.
22. Sugimoto S., Puddu P.E., Monti F., Schiariti M., Campa P.P., Marino B. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. J Thorac Cardiovasc Surg. 108:1994;455-466.
23. Bolli R. Postischemic myocardial 'stunning': pathogenesis, pathophysiology, and clinical relevance. In: Yellon DM, Jennings RB, editors. Myocardial Protection. The Pathophysiology of Reperfusion and Reperfusion Injury. New York: Raven Press Ltd., 1992:105-149.
24. Puddu P.E., Sugimoto S., Monti F., Iwashiro K., Dawodu A.A., Schiariti M., Chiavarelli R., Marino B., Campa P.P. Activation or block of adenosine triphoshate-sensitive potassium channel have opposite effects on postcardioplegic myocardial dysfunction, 'stunning'. A multivariate prediction based on relative operating characteristic curve. Cardiologia. 40:1995;667-677.
25. Walker D.M., Walker J.M., Pugsley W.B., Pattison C.W., Yellon D.M. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 27:1995;1349-1357.
26. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res. 77:1995;1030-1035.
27. Iwashiro K., Cassese M., Dawodu A.A., Monti F., Brancaccio G.L., Schiariti M., Sinatra R., Campa P.P., Puddu P.E. Stunning in isolated superfused human atrial muscle: protective effects of K-ATP channel activation with bimakalim pretreatment. Circulation (Abstract). 94:1996;I-549.
28. Puddu PE, Picard S, Iwashiro K, Criniti A, Dawodu AA, Monti F, La Francesca S, Campa PP. Contractile dysfunction following long (60 min) but not repeated shorter (5 min) hypoxia: a stunning model in isolated human atrial muscle. In: Puddu PE, Bing RJ, Campa PP, Poole-Wilson PA, editors. Congestive Heart Failure: From Basic Science to Therapeutics. Roma: Cardioricerca, 1997:97-120.
29. Schwinger R.H.G., Böhm M., Kock A., Uhlmann R., Uberfuhr P., Kreuzer E., Reichart B., Erdmann E. Force-frequency relation in human atrial and ventricular myocardium. Mol Cell Biochem. 119:1993;73-78.
30. Ross J.J., Miura T., Kambayashi M., Eising G.P., Ryu K.H. Adrenergic control of force-frequency relation. Circulation. 92:1995;2327-2332.
31. Davies C.H., Davia K., Bennett J.C., Pepper J.R., Poole-Wilson P.A., Harding S.E. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 92:1995;2540-2549.
32. Dawodu A.A., Monti F., Iwashiro K., Schiariti M., Chiavarelli R., Puddu P.E. The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol. 54:1996;237-249.
33. Mary-Rabine L., Albert A., Hordof A., Fenoglio J.J.J., Malm J.R., Rosen M.R. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res. 52:1983;188-199.
34. Carlos M.E., Smart S.C., Wynsen J.C., Sagar K.B. Dobutamine stress echocardiography for risk stratification after acute myocardial infarction. Circulation. 95:1997;1402-1410.
35. Brodde O.E., Michel M.C., Zerkowski H.R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 30:1995;570-584.
36. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res. 28:1994;303-311.
37. Dixon WJ. BMDP statistical software manual: to accompany the 7.0 software release. Berkeley: University of California Press, 1992:1-1500.
38. Dixon WJ, Merdian KL. ANOVA and regression with BMDP 5V. Los Angeles: Dixon Statistical Associates, 1992:1-193.
39. Ljung B. Vascular selectivity of felodipine. Drugs. 29(Suppl. 2):1985;46-58.
40. Askholt J., Nielsen-Kudak F. Felodipine, pharmacodynamics and pharmacokinetics in the isolated rabbit heart. Acta Pharmacol Toxicol (Copenhagen). 59:1986;17-26.
41. Ferrari R., Cargnoni A., Bernocchi P., Gaia G., Benigno M., Pasini E., Pedersini P., Ceconi C. Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection. Cardiovasc Drugs Ther. 10:1996;425-437.
42. Yusuf S. Calcium antagonists in coronary artery disease and hypertension: time for reevaluation? (Editorial). Circulation. 92:1995;1079-1082.
43. Levy J.V. Force-frequency relationship of human atrial muscle in vitro: beta adrenergic mechanisms. Arch Int Physiol Biochim. 76:1968;680-692.
44. Schomisch Moravec C., Schluter M.D., Paranandi L., Czerska B., Stewart R.W., Rosenkranz E., Bond M. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 82:1990;1973-1984.
45. Keon W.J., Labow R.S., Hendry P.J., Barry Y.A. The human atrial trabecula: effects of calcium and temperature. J Mol Cell Cardiol. 23:1991;357-364.
46. Holubarsch C., Hasenfuss G., Schmidt-Schweda S., Knorr A., Pieske B., Ruf T., Fasol R., Just H. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation. 88:1993;1228-1237.
47. Trautwein W., Kassebaum D.G., Nelson R.M., Hecht H.H. Electrophysiological study of human heart muscle. Circ Res. 10:1962;306-312.
48. Prasad K. Transmembrane potential and force of contraction of the normal and potassium-deficient human atrial tissue in vitro. Can J Physiol Pharmacol. 47:1969;1015-1024.
49. Gelband H., Bush H.L., Rosen M.R., Myerburg R.J., Hoffman B.F. Electrophysiologic properties of isolated preparations of human atrial myocardium. Circ Res. 30:1972;293-300.
50. Escande D., Loisance D., Planché C., Coraboeuf E. Age-related changes of action potential plateau shape in isolated human atrial fibers. Am J Physiol. 249:1985;H843-H850.
51. Puddu P.E., Schiariti M., Chiavarelli R., Monti F., Dawodu A.A., Lanti M., Terracciano C.M.N., Sugimoto S., Cassese M., Campa P.P. Nicorandil has different electrophysiologic effects in human as compared to guinea-pig atrial cells. Eur Heart J (Abstract). 13(Suppl.):1992;210.
52. Phillips P.J., Gwathmey J.K., Feldman M.D., Schoen F.J., Grossman W., Morgan J.P. Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. J Mol Cell Cardiol. 22:1990;99-110.
53. Bers D.M., Bassani R.A., Bassani J.W.M., Baudet S., Hryshko L.V. Paradoxical twitch potentiation after rest in cardiac muscle: increased fractional release of SR calcium. J Mol Cell Cardiol. 25:1993;1047-1057.
54. Schwinger R.H.G., Böhm M., Koch A., Schmidt U., Morano I., Eissner H.J., Überfuhr P., Reichart B., Erdmann E. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res. 74:1994;959-969.
55. Alvaro D., Angelico M., Catanfora A., Gaudio E., Gandin C., Santini M.T., Masella R., Capocaccia L. Improvement of estradiol 17 beta-D-glucoronide cholestasis by intravenous administration of dimethylethanolamide in the rat. Hepatology. 13:1991;1158-1172.
56. Mulieri L.A., Hasenfuss G., Ittleman F., Blanchard E.M., Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res. 65:1989;1441-1449.
57. Snow T.R., Bressler P.B. Oxygen sufficiency in working rabbit papillary muscle at 25°C. J Mol Cell Cardiol. 9:1977;595-604.
58. Hasenfuss G., Mulieri L.A., Leavitt B.J., Alpert N.R. Influence of isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium. J Mol Cell Cardiol. 26:1994;1461-1469.
59. Prabhu S.D., Freeman G.L. Postextrasystolic mechanical restitution in closed-chest dogs. Effect of heart failure. Circulation. 92:1995;2652-2659.
60. Pieske B., Kretschmann B., Meyer M., Holubarsch C., Weirich J., Posival H., Minami K., Just H., Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 92:1995;1169-1178.
61. Holubarsch C., Schneider R., Pieske B., Ruf T., Hasenfuss G., Fraedrich G., Posival H., Just H. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions. Circulation. 92:1995;2904-2910.
62. Warner A.L., Bellah K.L., Raya T.E., Roeske W.R., Goldman S. Effects of β-adrenergic blockade on papillary muscle function and the β-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Circulation. 86:1992;1584-1595.
63. Gauthier C., Laurent K., Charpentier F., Drouin E., Chevallier J.C., Le Marec H. Endomyocardial biopsies: a new approach for studying the electrical and mechanical properties of human ventricular myocardium. J Mol Cell Cardiol. 26:1994;1267-1271.
64. White M., Wiechmann R.J., Roden R.L., Hagan M.B., Wollmering M.M., Port J.D., Hammond E., Abraham W.T., Wolfel E.E., Lindenfeld J., Fullerton D., Bristow M.R. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation. 92:1995;2183-2189.
65. Hearse D.J. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res. 30:1995;1-17.